RESUMEN
Severe coagulopathy in a male patient with septicemia, renal failure, and obstructive jaundice secondary to cholelithiasis precluded safe endoscopic sphincterotomy. A temporary nasobiliary drain, inserted at endoscopic retrograde cholangiopancreatography, decompressed the biliary tree, allowing eventual safe sphincterotomy and bile duct clearance after correction of coagulopathy and improvement in his clinical condition.
Asunto(s)
Trastornos de la Coagulación Sanguínea/cirugía , Colangitis/cirugía , Colelitiasis/cirugía , Drenaje , Trombocitopenia/cirugía , Trastornos de la Coagulación Sanguínea/complicaciones , Colangitis/complicaciones , Colelitiasis/complicaciones , Conducto Colédoco/cirugía , Endoscopía , Humanos , Masculino , Persona de Mediana Edad , Trombocitopenia/complicacionesAsunto(s)
Pérdida Auditiva Provocada por Ruido/prevención & control , Ruido , Polímeros , Vibración , Elasticidad , Métodos , ViscosidadRESUMEN
A case of bacterial endocarditis which proved fatal in a 65-year-old edentulous male Caucasian with rheumatic valvular heart disease is reported. This occurred following dilatation of a benign oesophageal stricture with a Hurst mercury bougie. Transient low grade bacteraemia following upper gastrointestinal intubation is well documented but we are not aware of any published reports on bacterial endocarditis following this procedure and the possible implications of this case are discussed.
Asunto(s)
Dilatación/instrumentación , Endocarditis Bacteriana/etiología , Estenosis Esofágica/terapia , Anciano , Estenosis Esofágica/complicaciones , Humanos , Masculino , Válvula Mitral/microbiología , Boca Edéntula/complicaciones , Cardiopatía Reumática/complicaciones , Streptococcus/aislamiento & purificaciónRESUMEN
Transient bacteremia occurs in a variety of gastrointestinal procedures. Of 13 patients with a benign esophageal stricture treated as out-patients by the passage of Hurst mercury bougies only one developed transient bacteremia which occurred five minutes after dilation. We do not therefore recommend routine antibiotic prophylaxis for patients undergoing this type of management. Attention should be given to the manner in which dilators are cleaned and stored.
Asunto(s)
Dilatación/efectos adversos , Estenosis Esofágica/terapia , Sepsis/epidemiología , Humanos , Sepsis/etiologíaRESUMEN
The effect of continued alcohol intake on prognosis in alcoholic cirrhotics who have already bled from varices is controversial. To investigate the effect of alcohol intake on prognosis we studied 189 consecutive alcoholic cirrhotics admitted, for the first time, to the Royal Free Hospital with variceal bleeding. Sixty-six died within 30 days of admission and 23 were excluded from the study for other reasons. Of the 100 remaining 15 remained 'probably abstinent' over long-term follow-up, 29 drank occasionally and 56 continued to misuse/abuse alcohol. The percentage survival probability at 2 years was 66% in the probable abstainers, 68% in the occasional drinkers and 63% in the alcohol abuse/misuse group. There were no significant differences in either mortality or rebleeding rates between the three groups. A rebleeding index (designed to take account of the number of rebleeds per patient and the total length of follow-up) also failed to show any significant difference between the three groups. The Cox proportional hazard model was used to study the effect of the following factors on rebleeding and mortality; age, sex, alcohol use, Pugh's score, acute treatment received for initial variceal bleed and long-term treatment received for prevention of recurrent variceal haemorrhage. Pugh's score was significantly related to risk of death during follow-up (p = 0.0122), but none of the other factors was significantly related to risk of rebleeding or mortality. Using conventional methods to determine alcohol use we were unable to demonstrate significant effects of alcohol intake on rebleeding or mortality in alcoholic cirrhotics who had bled from oesophageal varices.
Asunto(s)
Consumo de Bebidas Alcohólicas/efectos adversos , Várices Esofágicas y Gástricas/fisiopatología , Hemorragia Gastrointestinal/fisiopatología , Cirrosis Hepática Alcohólica/mortalidad , Cirrosis Hepática Alcohólica/fisiopatología , Várices Esofágicas y Gástricas/etiología , Várices Esofágicas y Gástricas/mortalidad , Femenino , Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/mortalidad , Humanos , Cirrosis Hepática Alcohólica/complicaciones , Masculino , Persona de Mediana Edad , PronósticoRESUMEN
A double-blind randomized study in 230 Malaysian patients with duodenal ulcer was conducted to compare the proton-pump inhibitor, omeprazole 20 mg, given once daily in the morning, with ranitidine 300 mg, administered once daily at night. After 2 and 4 weeks of treatment, 222 and 220 patients, respectively, were evaluable according to the study protocol. Omeprazole produced significantly higher healing rates than ranitidine at both 2 weeks (75% versus 46%, respectively, P less than 0.0001) and 4 weeks (97% versus 83%, respectively, P = 0.001). Ulcer symptoms were relieved more rapidly by omeprazole than ranitidine. After 2 weeks, daytime epigastric pain was reported by 30% of ranitidine-treated patients but only by 15% of omeprazole-treated patients, which is a statistically significant difference (P = 0.004). No major clinical or biochemical side effects were recorded for either omeprazole or ranitidine. In conclusion, omeprazole 20 mg was found to be superior to ranitidine 300 mg administered once daily for the treatment of duodenal ulcer as measured by ulcer healing and pain relief.